Microbiology
-
Potential Antiviral Options against SARS-CoV-2 Infection
This article has 20 authors:Reviewed by ScreenIT
-
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
This article has 8 authors:Reviewed by ScreenIT
-
Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cells
This article has 4 authors:Reviewed by ScreenIT
-
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
This article has 5 authors:Reviewed by ScreenIT
-
Multiple introductions, regional spread and local differentiation during the first week of COVID-19 epidemic in Montevideo, Uruguay
This article has 7 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
This article has 14 authors:Reviewed by ScreenIT
-
Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
This article has 10 authors:Reviewed by ScreenIT
-
The coding capacity of SARS-CoV-2
This article has 17 authors:Reviewed by ScreenIT
-
A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs
This article has 12 authors:Reviewed by ScreenIT